After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
APLS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Apellis Pharmaceuticals Inc is $2.97B. A total of 1.55 million shares were traded on the day, compared to an average of 2.42M shares.
In the most recent transaction, Dunlop A. Sinclair sold 31,092 shares of APLS for 22.95 per share on Sep 19 ’25. After the transaction, the Director now owns 68,908 company shares. In a previous transaction on Sep 19 ’25, Dunlop A. Sinclair bought 93,276 shares at 22.95 per share.
Among the insiders who sold shares, Watson David O. disposed of 5,000 shares on Sep 16 ’25 at a per-share price of $24.34. This resulted in the General Counsel holding 118,730 shares of APLS after the transaction. In another insider transaction, Chopas James George sold 189 shares at $24.19 per share on Sep 15 ’25. Company shares held by the VP/Chief Accounting Officer now total 53,468.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, APLS has a high of $35.72 and a low of $16.10.
As of this writing, APLS has an earnings estimate of $0.91 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $2.03 per share and a lower estimate of -$0.61. The company reported an EPS of -$0.46 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $1.24, while its Total Shareholder’s Equity was $198.66M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APLS is Buy with a score of 4.04.
